Autopsy report · NCT00374257

UVB Phototherapy Treatment of Oral Chronic GVHD

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Low/slow accrual”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years 1 month before it stopped.
11 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Brigham and Women's Hospital
Sponsor type: University, hospital or other
Conditions: Oral Chronic Graft-versus-host Disease
Interventions: Narrow-Band UVB Phototherapy
Participants: 11
Sites: 2
Countries: United States

Trials that died the same way

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
“Slow accrual” (89% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.